CytoSorbents Corporation (CTSO)

[BuyMyAsk]

Their is a lot of common sense when it comes to investing in this stock.

The company is priced now under $20M. If we have a potential revenue producing medical device that we can sell the company should be worth $100M+ instantly. This is still a small cap stock at this point. Not even taking into consideration the fact that this device is used to help counter act a deadly disease with no current treatment available at the moment.

The management of this company handles themselves professionally. After the price ran to $0.40 Dr. Chan personally stated the BIO-MED report was wrong. What other CEO of an OTC stock would do this? He is a stand up person and this company will get what it deserves and so will it shareholders. The technology is there, the management is there, etc.

I am hoping trial results indicate that there is a 25-50% patient survival rate on CYTOSORB. That is good enough to market the device and for the price to go to $0.50 - $1.00 initially.